SCHEMBL25047321

SCHEMBL25047321

c1ccc(-c2cccc3ccccc23)c(-c2nc(-c3cccc4c3sc3ccccc34)cc(-c3cccc4c3sc3ccccc34)n2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.46
PARP14 Q460N5 1/20 0.40
MAPT P10636 2/20 0.39
PRKDC P78527 5/20 0.39
PIK3CD O00329 2/20 0.37
PIK3CB P42338 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
GPR3 P46089 1/20 0.36
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
HSD17B10 Q99714 2/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
NPC1 O15118 1/20 0.36
TP53 P04637 1/20 0.36
MAPK1 P28482 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
BRD4 O60885 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25047276 0.91 ALOX5 (0.43) ALOX5PARP14MAPTPRKDCPIK3CD
SCHEMBL25050296 0.90 ALOX5 (0.49) ALOX5PARP14MAPTPRKDCPIK3CD
SCHEMBL25049896 0.90 ALOX5 (0.40) ALOX5PARP14MAPTPRKDCPIK3CD
SCHEMBL22888852 0.90 ALOX5 (0.46) ALOX5PARP14MAPTPRKDCPIK3CD
SCHEMBL25050228 0.90 ALOX5 (0.46) ALOX5PARP14MAPTPRKDCPIK3CD
SCHEMBL15501716 0.90 ALOX5 (0.51) ALOX5PARP14MAPTPRKDCPIK3CD
SCHEMBL25050292 0.89 ALOX5 (0.44) ALOX5PARP14MAPTPRKDCPIK3CD
SCHEMBL25049960 0.88 ALOX5 (0.46) ALOX5PARP14MAPTPRKDCPIK3CD
SCHEMBL25047318 0.87 ALOX5 (0.48) ALOX5PARP14MAPTPRKDCPIK3CD
SCHEMBL25049971 0.87 ALOX5 (0.42) ALOX5PARP14MAPTPRKDCPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230047894-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO.,LTD. (JP) 2023-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230047894-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME AOC2, OR10J3, AOC3 ALOX5 3242/4885PARP14 2722/4885MAPT 3464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.